Common Contracts
3 similar Credit Agreement contracts by Trinity Biotech PLC
Second Amended and Restated Credit Agreement and GuarantyCredit Agreement • February 1st, 2024 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
Amended and Restated Credit Agreement and GuarantyCredit Agreement • February 22nd, 2023 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
Credit Agreement and GuarantyCredit Agreement • December 16th, 2021 • Trinity Biotech PLC • In vitro & in vivo diagnostic substances • New York
Credit Agreement And Guaranty, dated as of December 15, 2021 (this “Agreement”), among Trinity Biotech, Inc., a Delaware corporation (“U.S. Holdings”), Fitzgerald Industries International, Inc., a Delaware corporation (“U.S. Fitzgerald”) Clark Laboratories, Inc. (d/b/a Trinity Biotech (USA)), a New York corporation (“U.S. Clark”), Biopool US Inc., a Delaware corporation (d/b/a Trinity Biotech Distribution) (“U.S. Biopool”), Primus Corporation, a Missouri corporation (“U.S. Primus”), MarDx Diagnostics, Inc., a California corporation (“U.S. MarDx”), IMMCO Diagnostics, Inc., a Delaware corporation (“U.S. Immco” and together with U.S. Holdings, U.S. Fitzgerald, U.S. Clark, U.S. Biopool, U.S. Primus and U.S. MarDx, each a “Borrower” and collectively, the “Borrowers”), certain Guarantors from time to time parties hereto, the lenders from time to time party hereto (each, as a “Lender” and collectively, the “Lenders”), and Perceptive Credit Holdings III, LP, a Delaware limited partnership (“Pe
